Abstract Purpose of Review Since it first appeared, multisystem inflammatory syndrome in
children (MIS-C) associated with coronavirus disease 2019 (COVID-19) has been compared …

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has led to a diverse pattern of
myocardial injuries, including myocarditis, which is linked to adverse outcomes in patients …

Cardiovascular involvement is a major cause of inpatient and intensive care unit morbidity
related to Multisystem inflammatory syndrome in children (MIS-C). The objective of this study …

Multisystem inflammatory syndrome in children (MIS-C) is an immune-mediated
complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

OBJECTIVES To assess the prevalence of residual cardiovascular pathology by cardiac MRI
(CMR), ambulatory rhythm monitoring, and cardiopulmonary exercise testing (CPET) in …

Objective: This study aimed to evaluate the cardiovascular manifestations and surveillance
of multisystem inflammatory syndrome in children (MIS-C) and to determine the correlation …

COVID-19 (Coronavirus disease 2019) in children is usually mild. However, multiple organ
disorders associated with SARS-CoV-2 (severe acute respiratory syndrome-related …

Objective To assess the potential long-term cardiac effects after multisystem inflammatory
syndrome in children (MIS-C) with cardiovascular involvement in the acute phase. Study …

Myocarditis comprises many clinical presentations ranging from asymptomatic to sudden
cardiac death. The history, physical examination, cardiac biomarkers, inflammatory markers …

Introduction As we learn more about the novel multisystem inflammatory syndrome in
children (MIS-C) associated with COVID-19 infection, the protocols for long-term follow-up …